ABSTRACT
) mice using patch-clamp techniques. In WT VSMCs, the intracellular Ca 2؉ store-depleting agents cyclopiazonic acid (CPA) and 1,2-bis-(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid (BAPTA-AM) both evoked channel currents, which had unitary conductances of ϳ2 pS. In TRPC1 ؊/؊ VSMCs, CPA-induced channel currents had 3 subconductance states of 14, 32, and 53 pS. Passive depletion of intracellular Ca 2؉ stores activated whole-cell cation currents in WT but not TRPC1 ؊/؊ VSMCs. Differential blocking actions of anti-TRPC antibodies and coimmunoprecipitation studies revealed that CPA induced heteromeric TRPC1/C5 channels in WT VSMCs and TRPC5 channels in TRPC1 ؊/؊ VSMCs. CPA-evoked TRPC1/C5 channel activity was prevented by the protein kinase C (PKC) inhibitor chelerythrine. In addition, the PKC activator phorbol 12,13-dibutyrate (PDBu), a PKC catalytic subunit, and phosphatidylinositol-4,5-bisphosphate (PIP 2 ) and phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) activated TRPC1/C5 channel activity, which was prevented by chelerythrine. In contrast, CPA-evoked TRPC5 channel activity was potentiated by chelerythrine, and inhibited by PDBu, PIP 2 , and PIP 3 ] i had no effect in WT VSMCs. We conclude that agents that deplete intracellular Ca 2؉ stores activate native heteromeric TRPC1/C5 channels in VSMCs, and that TRPC1 subunits are important in determining unitary conductance and conferring channel activation by PKC, PIP 2 . Abnormal changes in [Ca 2ϩ ] i initiate excess vasoconstriction and hypertension, and also induce secretion of proinflammatory factors, and VSMC growth, proliferation, and migration, which are key features of VSMCs switching from contractile to synthetic phenotypes that contribute to vascular diseases, such as atherosclerosis (3) . Molecules involved in determining [Ca 2ϩ ] i in VSMCs are therapeutic targets for prevention and treatment of vascular disease. Canonical transient receptor potential (TRPC) channel proteins represent such molecular targets, and there is considerable interest in expression, activation mechanisms and functions of native TRPC channels in VSMCs.
The TRPC family of channel proteins is composed of 7 members (TRPC1-C7, with TRPC2, a pseudogene in humans), which associate with each other to form homomeric and heteromeric nonselective Ca 2ϩ -permeable cation channels (1) (2) (3) (4) (5) . Opening of TRPC channels mediates Ca 2ϩ influx pathways through 3 main mechanisms: inducing membrane depolarization and stimulation of voltagedependent Ca 2ϩ channels (VDCCs), increasing intracellular Na ϩ levels and activating Na ϩ /Ca 2ϩ exchangers in reverse mode, and direct Ca 2ϩ influx (1) (2) (3) (4) (5) . TRPC proteins are expressed throughout the vasculature, and they are implicated in controlling vascular physiology and pathology (1) (2) (3) . Physiological activation of TRPC channels by vasoconstrictors involves stimulation of G ␣q/11 -protein-coupled receptors linked to the phospholipase C (PLC) signaling cascade, which leads to phosphatidylinositol 4,5-bisphosphate (PIP 2 ) hydrolysis and generation of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP 3 ) (1-5). In addition, constitutively active G ␣i/o -protein-mediated stimulation of phospholipase D (PLD) and generation of DAG also activates TRPC channels in VSMCs (4, 5) . The molecular composition of TRPC channels is an important factor in determining channel activation mechanisms. Homomeric and heteromeric TRPC channels composed of TRPC3, TRPC6, and TRPC7 subunits are often termed classical receptor-operated channels (ROCs), as they are activated by DAG through a protein kinase C (PKC)-independent mechanism that does not involve intracellular Ca 2ϩ stores (1) (2) (3) (4) (5) . TRPC channels containing TRPC1 subunits (termed TRPC1 channels herein) are gated by DAG via a PKC-dependent action, and also by agents that deplete intracellular Ca 2ϩ stores (4 -8) . Vasoconstrictors activate both TRPC3/C6/C7 and TRPC1 channels at low concentrations, but only TRPC1 channels at higher concentrations (4, 5) . Concentration-dependent effects of vasoconstrictors on TRPC channels are proposed to be caused by TRPC1-mediated Ca 2ϩ influx coupled to PKC-dependent phosphorylation and inhibition of TRPC3/C6/C7 channels (9) . In summary, vasoconstrictor-evoked TRPC1 channels represent both ROCs (e.g., DAG production) and store-operated channels (SOCs; e.g., IP 3 -mediated release of intracellular Ca 2ϩ stores) (4, 5). There is evidence of a pivotal role for endogenous phosphoinositols (PIs), phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ), in activating TRPC1 channels (4, 5, 9, 10) . This hypothesis states that vasoconstrictor stimulation causes PKC-mediated phosphorylation of TRPC1 subunits through both receptorand store-operated pathways, which increases affinity for endogenous PIP 2 (or PIP 3 ) to associate with TRPC1 proteins, leading to channel opening (4, 5) . The present work investigates molecular evidence for this proposal of TRPC1 gating, by comparing properties and activation mechanisms of cation channel activity in VSMCs from wild-type (WT) and TRPC1-deficient (TRPC1 Ϫ/Ϫ ) mice. We used agents that deplete intracellular Ca 2ϩ stores instead of vasoconstrictors to evoke channel activity, as the former chemicals only activate TRPC1 channels, whereas the later agents have complex actions on both TRPC1 and TRPC3/C6/C7 channels in VSMCs (see above). Thus, agents that deplete Ca 2ϩ stores enable selective investigation of TRPC1 channel properties, which is the focus of the present work.
The present work concludes that agents that deplete intracellular Ca 2ϩ stores activate native heteromeric TRPC1/C5 channels in freshly isolated, contractile mesenteric artery VSMCs, and that TRPC1 subunits are important for conferring unitary conductance and activation by PKC, PIP 2 and PIP 3 . Moreover, TRPC1
Ϫ/Ϫ
VSMCs express homomeric TRPC5 channels, which are activated by a rise in [Ca 2ϩ ] i , and are inhibited by PKC, PIP 2 , and PIP 3 .
MATERIALS AND METHODS

Cell isolation
WT and TRPC1
Ϫ/Ϫ mice were sacrificed by cervical dislocation in accordance with the UK Animals Scientific Procedures Act, 1986. As described previously, TRPC1
Ϫ/Ϫ mice were viable and fertile with normal littler sizes compared to WT mice, and appeared healthy (12) . All animal protocols were carried out as specified by the St. George's, University of London, animal welfare committee. Single cells were prepared from mouse mesenteric arteries (first to third order) in physiological salt solution containing (mM): 126 NaCl, 6 KCl, 10 glucose, 11 HEPES, 1.2 MgCl 2 , and 1.5 CaCl 2 , adjusted to pH 7.2 with 10 M NaOH. Enzymatic digestion and VSMC isolation were subsequently carried out using methods previously described (9) .
Electrophysiology
Single-channel cation currents, using cell-attached, inside-out and outside-out patch configurations, and whole-cell recordings were made with an AXOpatch 200B amplifier (Axon Instruments, Union City, CA, USA) at room temperature (20 -23°C), as described previously (9) . Single-channel I/V relationships were obtained by manually altering the holding potential of Ϫ70 mV between Ϫ120 and ϩ120 mV. In WT VSMCs, TRPC1/C5 single-channel current records were filtered between 0.1 and 0.5 kHz (Ϫ3 dB, low-pass 8-pole Bessel filter; Frequency Devices model LP02; Scensys, Aylesbury, UK) and acquired at 1-5 kHz (Digidata 1322A and pCLAMP 9.0 software; Molecular Devices, Sunnydale, CA, USA), whereas TRPC5 channel currents expressed in TRPC1 Ϫ/Ϫ VSMCs were filtered between 0.5 and 1 kHz and sampled between 5 and 10 kHz. Single-channel current amplitudes were calculated from idealized traces of Ն30 s in duration using the 50% threshold method and analyzed using pCLAMP 9.0 software. TRPC1/C5 events lasting for Ͻ1.32-6.64 ms and TRPC5 events lasting for Ͻ0.64 -1.32 ms (ϫ2 rise time of filtering used, see above) were excluded during creation of idealized traces, to maximize the number of channel openings reaching their full current amplitude. Open probability (NP O ) was used as a measure of channel activity and was calculated automatically by pCLAMP 9. Single-channel current amplitude histograms were plotted from the event data of the idealized traces, using bin widths appropriate for the unitary amplitudes, e.g., 0.01 pA for TRPC1/C5 and 0.05 pA for TRPC5 channels. Amplitude histograms were fitted using gaussian curves, with peak values corresponding to channel open levels. Mean channel amplitudes at different membrane potential were plotted, and current-voltage relationships curves were fitted by linear regression with the gradient determining conductances values.
Whole-cell currents were filtered at 1 kHz and sampled at 2 kHz. To evaluate I/V relationships of whole-cell currents, voltage ramps from ϩ100 to Ϫ150 mV (750 ms duration) were applied every 30 s from a holding potential of 0 mV. 
Immunoprecipitation and Western blot analysis
Dissected tissues were flash-frozen and stored in 10 mM Tris-HCl (pH 7.4) at Ϫ80°C for subsequent use. Briefly (13) , proteins from total cell lysate were extracted and then immunoprecipitated using antibodies raised against TRPC1 or TRPC5 proteins with a Millipore Catch and Release kit (Millipore, Billerica, MA, USA) followed by 1-dimensional protein gel electrophoresis (10 -20 g total protein/lane). Separated proteins were transferred onto PVDF membranes, and then membranes were incubated with anti-TRPC1 or -TRPC5 antibodies (1 g/ml) at 4°C overnight. Visualization was carried out using a horseradish peroxidase-conjugated secondary antibody (80 ng/ml) and ECL chemiluminescence reagents (Pierce, Rockford, IL, USA) for 1 min and exposure to photographic films. Data shown represent n values of Ն3 separate experiments.
Solutions and drugs
In cell-attached patch experiments, the membrane potential was set to ϳ0 mV by perfusing cells in a KCl external solution containing (mM): 126 KCl, 1.5 CaCl 2 , 10 HEPES, and 11 glucose, adjusted to pH 7.2 with 10 M KOH. Nicardipine (5 M) was also included to prevent smooth muscle cell contraction by blocking Ca 2ϩ entry through voltage-dependent Ca 2ϩ channels. The pipette solutions used in cell-attached and inside-out patch experiments contained (mM) 126 NaCl, 1.5 CaCl 2 , 10 HEPES, and 11 glucose, adjusted to pH 7.2 with 10 M NaOH. Nicardipine (5 M), 100 M DIDS, and 100 M niflumic acid were included to block voltage-dependent Ca 2ϩ channels (VDCCs) and Ca 2ϩ -activated and swell-activated Cl Ϫ conductances. The external solution used in inside-out patches and for the patch pipette solution used in outside-out patches were both K ϩ -free and contained (mM) 18 CsCl, 108 cesium aspartate, 1.2 MgCl 2 , 10 HEPES, 11 glucose, 1 Na 2 ATP, and 0.2 NaGTP, adjusted to pH 7.2 with Tris. Standard free [Ca 2ϩ ] i was set at 100 nM by adding 0.48 mM CaCl 2 ϩ 1 mM 1,2-bis-(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA) and was increased further by adding CaCl 2 (according to EQCAL software; Biosoft, Cambridge, UK). The external solution used in outside-out patches was K ϩ free and contained (mM) 126 NaCl, 1.5 CaCl 2 , 10 HEPES, and 11 glucose, adjusted to pH 7.2 with 10 M NaOH.
In whole-cell recording experiments, the external solution was composed of (mM) 135 Na-methanesulfonate, 10 CsCl, TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 antibodies were generated (Genscript, Piscataway, NJ, USA) using peptide sequences from previously characterized putative intracellular regions of TRPC channels (14) . Anti-TRPC1 and -TRPC5 antibodies were also obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All drugs were purchased from Calbiochem (Nottingham, UK), Sigma (Poole, UK) or Tocris (Bristol, UK), and agents were dissolved in distilled H 2 O or DMSO (0.1%). DMSO alone had no effect on channel activity. Data values are means Ϯ se of n cells. Statistical analysis was carried out using paired (comparing effects of agents on the same cell) or unpaired (comparing effects of agents between cells) Student's t test with the level of significance set at P Ͻ 0.05.
RESULTS
Biophysical properties conferred by TRPC1 to cyclopiazonic acid (CPA)-evoked cation channel activity in VSMCs
We initially investigated biophysical properties conferred by TRPC1 to native cation channel currents activated by agents known to deplete organelle Ca 2ϩ stores in acutely isolated mesenteric artery VSMCs from WT and TRPC1 Ϫ/Ϫ mice. We used CPA, which depletes Ca 2ϩ stores by inhibiting sarcoplasmic recticulum (SR) Ca 2ϩ -ATPases, and also BAPTA-AM, a cell-permeable Ca 2ϩ chelator, which causes passive depletion of Ca 2ϩ stores. In WT and TRPC1
VSMCs, bath application of 10 M CPA induced channel activity in cell-attached patches held at Ϫ70 mV, which had similar mean NP O values of 0.62 Ϯ 0.02 (nϭ22) and 0.88 Ϯ 0.04 (nϭ27), respectively. However, CPA-evoked native cation channel currents had much smaller singlechannel conductance in WT compared to TRPC1
VSMCs.
In WT VSMCs, CPA-induced channel currents had a mean unitary amplitude of Ϫ0.21 Ϯ 0.01 pA at Ϫ70 mV (nϭ22), which represented an unitary channel conductance of 2.2 pS that had an extrapolated reversal potential (E r ) of about ϩ20 mV (Fig. 1A) . In contrast, TRPC1
Ϫ/Ϫ VSMCs expressed CPA-induced channel currents, which had 3 distinct open levels between Ϫ1 and Ϫ4 pA at Ϫ70 mV that related to conductance values of 14, 32, and 53 pS (Fig. 1B) . In addition, all three subconductance states had values of E r ϳ 0 mV (Fig. 1B) .
In WT VSMCs, bath application of 50 M BAPTA-AM-induced channel currents with a mean NP O of 0.58 Ϯ 0.07 (nϭ6) in cell-attached patches held at Ϫ70 mV, which had a unitary conductance of 2.1 pS and an extrapolated E r of about ϩ23 mV ( Fig. 2A ). An interesting finding was that BAPTA-AM did not activate channel activity in TRPC1 Ϫ/Ϫ VSMCs (nϭ7, Fig. 2B ).
TRPC1 contributes to whole-cell currents evoked by passive depletion of intracellular Ca 2؉ stores in VSMCs
To investigate whether TRPC1 channels mediate genuine SOCs, defined as channels evoked by depletion of Ca 2ϩ levels within intracellular Ca 2ϩ stores and not a rise in [Ca 2ϩ ] i , we compared macroscopic whole-cell currents evoked by passive Ca 2ϩ store depletion in VSMCs from WT and TRPC1 Ϫ/Ϫ mice. The archetypical and most characterized SOC is the calcium-release-activated channel (I crac ), which is mediated by Orai1 proteins (15, 16 VSMCs, whole-cell currents slowly developed following patch rupture into whole-cell configurations, which reached a mean peak current density of Ϫ2.02 Ϯ 0.21 pA/pF (nϭ9) at Ϫ80 mV after 5 min (Fig. 3A) . Whole-cell currents evoked by passive depletion exhibited a mean current-voltage relationship, which displayed relative Sshaped rectification and an E r of about ϩ20 mV (Fig. 1A) . In contrast, passive store depletion failed to activate whole-cell currents in TRPC1 Ϫ/Ϫ VSMCs (nϭ9, Fig. 3B ).
CPA activates native heteromeric TRPC1/C5 channels in WT and homomeric TRPC5 channels in TRPC1 ؊/؊ VSMCs
The distinct conductance values of CPA-evoked cation channels in WT and TRPC1 Ϫ/Ϫ VSMCs indicate that these two channels have distinct molecular compositions. We used anti-TRPC antibodies as blocking agents of channel activity and coimmunoprecipitation (17) to provide evidence that native CPA-induced channel activity is composed of heteromeric TRPC1/C5 channel structures in WT VSMCs and homomeric TRPC5 channels in TRPC1 Ϫ/Ϫ VSMCs. Channel activities were initially activated by 10 M CPA in cell-attached patches, and then patches were excised into the insideout configuration, in which channel activity was maintained (up to 30 min), allowing anti-TRPC antibodies (1:200) raised against putative intracellular epitopes to be applied to the cytosolic surface of patches. In WT VSMCs, anti-TRPC1 and anti-TRPC5 antibodies produced Ͼ90% inhibition of CPA-induced channel activity (Fig. 4A) . Anti-TRPC1 and anti-TRPC5 antibodies preincubated with their antigenic peptides, and anti-TRPC3, anti-TRPC4, anti-TRPC6, and anti-TRPC7 anti- , that related to a conductance of 2.1 pS between Ϫ120 and Ϫ50 mV, and an extrapolated E r of about ϩ20 mV (right panel). B) BAPTA-AM had no effect on quiescent cell-attached patches from TRPC1
Ϫ/Ϫ VSMCs.
bodies had no effect on channel activity (Fig. 4A) . In contrast, CPA-induced channel activity expressed in TRPC1 Ϫ/Ϫ VSMCs was only inhibited by anti-TRPC5 antibodies, and this inhibition was prevented by incubating the anti-TRPC5 antibody with its antigenic peptide (Fig. 4B) . In WT mesenteric artery tissue lysates, immunoprecipitation with anti-TRPC1 (Fig. 4C) or anti-TRPC5 (Fig. 4D ) followed by immunoblotting with anti-TRPC1 or anti-TRPC5 revealed expression and association between TRPC1 and TRPC5 proteins. TRPC1
Ϫ/Ϫ tissue lysates also expressed TRPC5 proteins (Fig. 4D) , but as expected, these lysates did not express TRPC1 proteins (Fig. 4C, D) . 
PKC dependence of channel activation by storedepleting agents is conferred by TRPC1 proteins
Studies have shown that native TRPC channels evoked by agents that deplete Ca 2ϩ stores in VSMCs require an obligatory role for PKC (4 -8, 10, 11) . Here, we provide molecular evidence that TRPC1 confers this obligatory role for PKC in activation of native TRPC channel by CPA. In WT VSMCs, the mean NP O of CPA-induced TRPC1/C5 channel activity was significantly reduced from 0.63 Ϯ 0.05 to 0.03 Ϯ 0.01 by chelerythrine (3 M), a PKC inhibitor, in cell-attached patches held at Ϫ70 mV (nϭ5, P Ͻ 0.01, Fig. 5A ). Consistent with these results, bath application of the PKC activator, phorbol 12,13-dibutyrate (PDBu; 1 M) activated 2-pS channels with a mean NP O of 0.47 Ϯ 0.05, which was significantly inhibited to 0.03 Ϯ 0.01 by 3 M chelerythrine in cell-attached patches held at Ϫ70 mV (nϭ5, PϽ0.01, Fig. 5A ). Moreover, a PKC catalytic subunit (0.01 U/ml) also activated 2-pS channels with a mean NP O of 0.21 Ϯ 0.04, which was significantly attenuated to 0.02 Ϯ 0.01 by 3 M chelerythrine in inside-out patches held at Ϫ70 mV (nϭ7, PϽ0.05, Fig. 5A ).
In contrast to the excitatory actions of PKC on TRPC1/C5 channels in WT VSMCs, PKC had inhibitory effects on TRPC5 channel activity in TRPC1 
TRPC1 proteins confer channel activation by PIP 2 and PIP 3
Endogenous PIP 2 and PIP 3 are also reported to have essential roles in activation of native TRPC channels consisting of TRPC1 in VSMCs (4, 5, 10 -13). Here, we show that TRPC1 confers excitatory actions of PIP 2 and PIP 3 on native TRPC1/C5 channels. Figure 6A shows that in WT VSMCs, bath application of the watersoluble analogues, 10 M diC8-PIP 2 and 10 M diC8-PIP 3 , to the cytosolic surface of inside-out patches activated 2-pS channels, which had mean NP O values that were significantly inhibited from 0.45 Ϯ 0.03 to 0.03 Ϯ 0.01 (nϭ8, PϽ0.01) and 0.51 Ϯ 0.05 to 0.05 Ϯ 0.01, respectively, at Ϫ70 mV (nϭ6, PϽ0.01) by chelerythrine (3 M).
In contrast, in TRPC1 Ϫ/Ϫ VSMCs, 10 M diC8-PIP 2 (nϭ6) and 10 M diC8-PIP 3 (nϭ6) did not activate channel activity in quiescent patches (data not shown), but these PIs did inhibit CPA-induced TRPC5 channel activity. In these experiments, channels were initially activated by 10 M CPA in cell-attached patches, and then patches were excised into the inside-out configuration, in which channel activity was maintained (up to 30 min), allowing PIs to be applied to the cytosolic surface of patches. The mean NP O of CPA-evoked TRPC5 channel activity in TRPC1 Ϫ/Ϫ VSMCs was greatly attenuated from 0.89 Ϯ 0.11 to 0.13 Ϯ 0.03 (nϭ8, PϽ0.01) by 10 M diC8-PIP 2 and from 0.91 Ϯ 0.14 to 0.05 Ϯ 0.02 by 10 M diC8-PIP 3 at Ϫ70 mV (nϭ7, PϽ0.01, Fig. 6B ).
Low La
3؉ concentrations activate cation channel currents with similar conductances to CPA-evoked channels in native WT and TRPC1
؊/؊ VSMCs
The present study indicates that WT VSMCs express native heteromeric TRPC1/TRPC5 channels, whereas TRPC1 Ϫ/Ϫ VSMCs contain homomeric TRPC5 channels. We provided further evidence for TRPC5 subunits contributing to both these channel structures by studying the effect of low external concentrations of La 3ϩ , known to activate expressed TRPC5 channels (18, 19) on VSMCs from WT and TRPC1 Ϫ/Ϫ mice. Bath application of 10 M La 3ϩ activated channel activity in outside-out patches from WT and TRPC1 Ϫ/Ϫ VSMCs, which had a unitary conductance of 2.3 pS and subconductance states of 14, 33, and 54 pS at positive membrane potentials (Fig. 7) , and a slightly lower conductance value of 1.5 pS and subconductance values of 9, 21, and 38 pS at negative membrane potentials (Fig. 7) . The similarity between the conductance values of La 3ϩ -evoked channel current compared to CPA-evoked channel currents in VSMCs from WT and TRPC1 Ϫ/Ϫ mice provide further support for involvement of TRPC5 subunits in the composition of both these CPA-evoked channels.
Native homomeric TRPC5 channels are activated by a rise in [Ca 2؉ ] i
There is currently no information on the properties or activation mechanisms of native TRPC5 channels. Expressed TRPC5 channels are activated or potentiated by a rise in [Ca 2ϩ ] i , which may involve calmodulin (CaM)-dependent processes (19 -22) , and we show that [Ca 2ϩ ] i activates TRPC5 channels in TRPC1 Ϫ/Ϫ VSMCs. Bath application of an intracellular solution containing 100 nM Ca 2ϩ to the cytosolic surface of inside-out patches did not activate channel activity (Fig. 8A) , but increasing the concentration of Ca 2ϩ from 100 to 200 nM activated cation channel currents with subconductance states of 14, 30, and 55 pS (Fig. 8A, B) . The concentration-dependent increase in channel activity produced by [Ca 2ϩ ] i had an effective half-maximal concentration (EC 50 ) of 467 nM (Fig. 8C) . Channel activity activated by 800 nM Ca 2ϩ was significantly inhibited by anti-TRPC5 but not by anti-TRPC5 antibodies preincubated with their antigenic peptide or anti-TRPC1 antibodies (Fig. 8D) . It should be noted that increasing [Ca 2ϩ ] i to 1.6 M did not activate any channel activity in WT VSMCs.
DISCUSSION
The present work investigates the role of TRPC1 proteins in native single TRPC channels activated by agents that deplete intracellular Ca 2ϩ stores in freshly isolated, contractile VSMCs, which were acutely isolated from mesenteric arteries of WT and TRPC1 Ϫ/Ϫ mice. We provide conclusive evidence that these agents activate heteromeric TRPC1/C5 channels in WT VSMCs and that TRPC1 subunits are important in determining unitary conductance and conferring channel activation by PKC, PIP 2 , and PIP 3 . In contrast, TRPC1
Ϫ/Ϫ VSMCs express homomeric TRPC5 channels, which are activated by increasing [Ca 2ϩ ] i , and inhibited by PKC, PIP 2 , and PIP 3 .
TRPC1 is a determinant of biophysical properties of native TRPC channels in VSMCs
VSMCs express two distinct TRPC channel groups, TRPC1 and TRPC3/C6/C7, which are both activated by vasoconstrictors, with low concentrations activating both TRPC1 and TRPC3/C6/C7 channels and high concentrations only inducing TRPC1 channels (4, 5) . Ϫ/Ϫ VSMCs, LA 3ϩ -activated cation channel currents (left panel) with 3 subconductances between 9 -38 pS at negative membrane potentials, and 14 -54 pS at positive potentials, which all had E r of ϳ0 mV (right panel).
Concentration-dependent actions of vasoconstrictors on different TRPC channel groups are, in part, mediated by TRPC1-mediated Ca 2ϩ influx, causing PKCdependent phosphorylation and inhibition of TRPC3/ C6/C7 channels (9) . In contrast, agents that deplete intracellular Ca 2ϩ stores only activate TRPC1 channels (4, 5); therefore, we used agents that deplete Ca 2ϩ stores to allow selective investigation of TRPC1 channel properties. In WT VSMCs, CPA activated cation channel currents with a unitary conductance of ϳ2 pS and an E r of about ϩ20 mV. In contrast, TRPC1
Ϫ/Ϫ VSMCs exhibited CPA-evoked cation channel currents with 3 subconductance states of 13, 32, and 53 pS and E r of 0 mV. Inclusion of 20 mM BAPTA with no added Ca 2ϩ in the patch pipette solution to induce passive depletion of intracellular Ca 2ϩ stores activated whole-cell currents, which displayed S-shaped I/V relationships that had E r of about ϩ20 mV, in WT VSMCs but failed to induce any currents in TRPC1 Ϫ/Ϫ VSMCs. These findings demonstrate that TRPC1 is pivotal for conferring unitary conductance to native TRPC channels. The positive E r values of single-channel and whole-cell currents in WT compared to those in TRPC1 Ϫ/Ϫ VSMCs also suggest that TRPC1 confers significant Ca 2ϩ permeability to native TRPC channels. Contribution of TRPC1 to channel composition will, therefore, have important consequences for the physiological role of native TRPC channels in VSMCs.
Openings of nonselective cation channels are considered to initiate excitation of VSMCs and vasoconstriction, although recently TRPC1 channels have also been adjudged to contribute to vessel relaxation. Activation of TRPC1 channels are proposed to induce spatially restricted increases in [Ca 2ϩ ] I , which stimulate Ca 2ϩ -activated K ϩ channels (BK Ca ) that lead to relaxation of rat aorta (23) . Furthermore, TRPC1-mediated relaxations may also be caused by negative interactions between TRPC1 and TRPC3/C6/C7 channels (9). However, TRPC1 has been shown to contribute to depolarizations associated with vasoconstriction and vasomotion (24) . The present data support the ideas that TRPC1 contributes to TRPC channels in VSMCs, which are involved in producing direct excitatory actions through increasing membrane permeability to Na ϩ and Ca 2ϩ , and also indirect inhibitory effects through simultaneous inhibition of TRPC3/C6/C7 channels, and activation of BK Ca .
Native heteromeric TRPC1/C5 channels are expressed in WT VSMCs
The vastly different conductance values of CPA-evoked channel currents in WT and TRPC1 Ϫ/Ϫ VSMCs provides evidence that these channels have distinct molecular identities from each other. We investigated the molecular identity of these channels by using antibodies raised against TRPC subtypes as blocking agents, which has previously been used as an effective method of investigating native channel composition in other vascular preparations (17) . In WT VSMCs, CPA-evoked channel activity was inhibited by anti-TRPC1 and anti-TRPC5 antibodies, whereas CPA-induced channel activity in TRPC1 Ϫ/Ϫ VSMCs was only prevented by anti-TRPC5 antibodies. Antibodies for TRPC3, TRPC4, TRPC6, and TRPC7 had no effect on channel activity in WT or TRPC1 Ϫ/Ϫ VSMCs, which indicates that these TRPC subunits are not involved in the composition of these CPA-evoked channels. Coimmunoprecipitation experiments reveal that TRPC1 and TRPC5 proteins are both expressed and coassociate with each other in WT mesenteric artery tissue lysates, whereas only TRPC5 proteins are expressed in TRPC1 Ϫ/Ϫ lysates. The inhibition of CPA-evoked channel activity and identification of a single protein band in VSMCs and tissue lysates from WT but not TRPC1 Ϫ/Ϫ mice indicates that the anti-TRPC1 antibody used in the present study had high selectivity.
Previous work on native and expressed TRPC channels support our evidence that native CPA-evoked cation channels in WT VSMCs are mediated by heteromeric TRPC1/C5 channels with a conductance of ϳ2 pS, and that TRPC1
Ϫ/Ϫ VSMCs express homomeric TRPC5 channels with subconductance states between 15 and 55 pS. The 2-pS TRPC1/C5 channels present in WT VSMCs have similar biophysical properties to previously described channel activity evoked by agents that deplete Ca 2ϩ stores in rabbit vascular preparations (17, 25, 26) . Studies concluded that heteromeric TRPC1/C5 structures also mediated these native TRPC channels in rabbit mesenteric artery VSMCs (7, 17) . Moreover, it is proposed that TRPC1 and TRPC5 provide a molecular template with additional TRPC6 or TRPC7 subunits for composition of native channels in rabbit coronary artery and portal vein VSMCs (7, 17) , respectively. Coexpression of TRPC1 and TRPC5 in cell lines produces functional heteromeric channels with conductances of 5 pS, whereas expressed homomeric TRPC5 channels have conductances between 38 and 63 pS (19, 27, 28) , which are similar to the conductances of the channels recorded in the present study.
TRPC1 confers an obligatory role for PKC in activation of CPA-evoked TRPC1/C5 channels, and is also responsible for activation of these channels by PIP 2 and PIP 3 The present data provides evidence that PKC is obligatory for activation of native TRPC1/C5 channels by agents that deplete Ca 2ϩ stores in WT VSMCs. In addition, PIP 2 and PIP 3 also activate native TRPC1/C5 channels. Furthermore, our data indicate that TRPC1 confers these excitatory actions of PKC, and PIP 2 and PIP 3 on TRPC1/C5 channels. CPA-and BAPTA-AMevoked TRPC1/C5 channel activity were inhibited by the PKC inhibitor chelerythrine, and the PKC activator, PDBu, plus a PKC catalytic subunit activated 2 pS channels, which were inhibited by chelerythrine. PIP 2 and PIP 3 applied to the intracellular surface of quiescent isolated patches evoked channel activity with conductances of ϳ2 pS, which were prevented by chelerythrine. These data indicate that PKC activity is also important for activation of TRPC1/C5 channels by PIP 2 and PIP 3 . As expected for actions conferred by TRPC1, the excitatory effects of PKC, PIP 2 , and PIP 3 on TRPC1/C5 channel activities were absent in TRPC1 Ϫ/Ϫ VSMCs.
These data are consistent with findings that show that interactions between PKC and endogenous PIP 2 /PIP 2 govern activation of native channels containing TRPC1 subunits in VSMCs (4, 5, 10, 11) . The hypothesis is that CPA and PDBu activate channel activity by inducing PKC-dependent phosphorylation of TRPC1 proteins, which increases the affinity of endogenous PIP 2 and PIP 3 tethered to TRPC1 proteins to act as activating ligands.
Consequently, channel activation by PIP 2 and PIP 3 is also prevented by PKC inhibition, as PKC is obligatory for binding of PIs to TRPC1 proteins. PKC has also been proposed to be important for store-operated TRPC1 activation in cultured human endothelial cells (29) and in cultured human glomerular mesangial cells, which are thought to be composed of TRPC1 and TRPC4 subunits (30 -32) . To date, the hypothesis that PIs are essential components in activating channelcontaining TRPC1 subunits is a novel discovery.
Homomeric TRPC5 channels are expressed in TRPC1
؊/؊ VSMCs CPA stimulates channel activity in TRPC1 Ϫ/Ϫ VSMCs, which has three conductance states of 14 pS, 32 pS, and 53 pS. These conductance levels are likely to represent subconductance states as the conductance values are not multiples of the lowest conductance level, the three open levels are observed in all patches and at low open probabilities, all three conductance levels had similar E r , and multiple subconductance states seem to be a characteristic of native TRPC channels in VSMCs, which do not contain TRPC1 (8, 33, 34) .
Several lines of evidence indicate that CPA activates homomeric TRPC5 channels in TRPC1 Ϫ/Ϫ VSMCs. CPA-evoked native channels in TRPC1 Ϫ/Ϫ VSMCs and expressed TRPC5 proteins have similar conductances of 15-55 and 38 -55 pS, respectively (19, 27) . CPAevoked channel activity in TRPC1 Ϫ/Ϫ VSMCs was only inhibited by anti-TRPC5 antibodies. Low concentrations of external La 3ϩ , which selectively activates expressed TRPC5 channels (18, 19) , induced native cation channel activities that had similar conductances to CPA-evoked channels in WT and TRPC1 Ϫ/Ϫ VSMCs. The slightly lower conductance values of La 3ϩ -activated channel currents compared to CPA-evoked channel currents at negative membrane potentials in both WT and TRPC1 Ϫ/Ϫ VSMCs probably reflects simultaneous channel block and channel activation by La 3ϩ , as observed with expressed TRPC5 channels in cell lines (18) .
We believe this is the first description of a native homomeric TRPC5 channel in any cell type, and accordingly, activation mechanisms of native TRPC5 channels are not known. ] i (20 -22) . Our data also show that TRPC5 channel activity activated by CPA in TRPC1 Ϫ/Ϫ VSMCs is inhibited by PKC, PIP 2 , and PIP 3 . Previous data have shown that PKC inhibits expressed TRPC5 channel activity, probably via a mechanism involving phosphorylation of serine-712 (35, 36) . In addition, PIP 2 has both excitatory and inhibitory actions on expressed TRPC5 channels (37, 38) . The present work is the first study to show that PIP 3 also regulates TRPC5 channel activation.
The opposing excitatory actions of PKC and PIP 2 and PIP 3 on TRPC1/C5 channels (see above) vs. their inhibitory effects on TRPC5 channels is an intriguing observation, as it suggests that properties conferred by TRPC1 dominants over characteristics of TRPC5 subunits in a native heteromeric TRPC1/C5 channel structure. Why this is the case is not known; it may be a consequence of TRPC1:TRPC5 subunit stoichiometry within the putative tetrameric structure. However, these findings strongly impress the importance of studying properties of native TRPC channels in their physiological environment, and not just investigating properties of individual TRPC subunits using expression systems.
Approaches used to study native single TRPC channels
Investigations into the properties of TRPC1 channels in VSMCs have generally manipulated TRPC1 protein expression using antisense (AS) or small interference RNA (siRNA) technologies, and then measured macroscopic signals, such as whole-cell conductances and Ca 2ϩ signals (17) . AS or siRNA studies have provided important information, but as they require 48 -72 h to down-regulate channel proteins, these procedures are more appropriate for studying properties of synthetic VSMCs than contractile VSMCs. In addition, AS and siRNA may be susceptible to artifacts, and nonspecific effects (39) , and macroscopic signals may contain multiple molecular mechanisms. In an attempt to circumvent some of these issues to enable us to measure single molecular mechanisms in contractile VSMCs, we recorded single native TRPC channel activity in acutely isolated VSMCs from WT and TRPC1 Ϫ/Ϫ mice, and used anti-TRPC antibodies as blocking agents (17) . It must also be acknowledged that there may also be issues with this experimental approach, such as the selectivity of antibodies and pharmacological agents used and that transgenic mice may contain compensatory changes in expression levels of other TRPC subtype genes (40) . However, compensatory changes in TRPC subtype genes were not previously observed in cerebral artery and thoracic aorta from TRPC1 Ϫ/Ϫ mice (12) . We believe that an important outcome of the present work is the successful use of complementary molecular and pharmacological approaches to investigate properties conferred by a TRPC subunit which contributes to a native single TRPC channel structure in contractile VSMCs.
Comparison of the present work with an earlier study (12) reveals interesting differences in macroscopic signals purported to involve TRPC conductances. Our work clearly demonstrates that passive depletion, a defining activation procedure for genuine SOCs, activates a wholecell cation conductance in WT but not TRPC1 Ϫ/Ϫ VSMCs, which indicates that TRPC1 contributes to SOC in mesenteric artery VSMCs. However, Dietrich et al. (12) showed that current densities and current-voltage relationships of CPA-evoked whole-cell cation conductances in cerebral artery VSMCs were similar in WT and TRPC1 Ϫ/Ϫ mice, even though functional TRPC1 and TRPC5 proteins are expressed in cerebral artery VSMCs (41) (42) (43) (44) . Reasons for these differences in the involvement of TRPC1 are not known, but they may involve differences between vascular beds and experimental protocols. Also, other TRPC subtypes or other TRP/Orai channel proteins may underlie native CPA-induced whole-cell currents in cerebral artery VSMCs. Functional Orai1 proteins are expressed in synthetic VSMCs but are not reported to be present in freshly isolated VSMCs with contractile phenotypes, as used in the present study (16, (45) (46) (47) . It should be also noted that passive depletion did not activate whole-cell currents with properties resembling those of I crac or Orai1 currents (15, 16) 
in contractile TRPC1
Ϫ/Ϫ VSMCs. In summary, the present study provides molecular evidence that TRPC1 forms native heteromeric TRPC1/C5 channels in VSMCs with a contractile phenotype, which are activated by agents that deplete Ca 2ϩ stores. Moreover, TRPC1 confers activation by PKC, PIP 2 , and PIP 3 on these native channels.
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